This year will be a doozy in terms of drugs going off-patent – undoubtedly a point of contention that will be discussed at length at next week’s J.P. Morgan Healthcare Conference.
Dickson Data put together an excellent infographic that illustrates the various drugs that will be prey for generics makers this year.
